1. Home
  2. OSIS vs HAE Comparison

OSIS vs HAE Comparison

Compare OSIS & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OSI Systems Inc. (DE)

OSIS

OSI Systems Inc. (DE)

HOLD

Current Price

$270.63

Market Cap

4.7B

Sector

Technology

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$59.91

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSIS
HAE
Founded
1987
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
3.0B
IPO Year
1997
1996

Fundamental Metrics

Financial Performance
Metric
OSIS
HAE
Price
$270.63
$59.91
Analyst Decision
Strong Buy
Buy
Analyst Count
6
9
Target Price
$280.33
$85.38
AVG Volume (30 Days)
207.8K
652.4K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
18.02
44.54
EPS
3.39
2.46
Revenue
$1,089,286,000.00
$910,373,000.00
Revenue This Year
$9.86
N/A
Revenue Next Year
$5.53
$5.46
P/E Ratio
$81.40
$24.17
Revenue Growth
13.35
N/A
52 Week Low
$164.08
$47.32
52 Week High
$306.12
$87.32

Technical Indicators

Market Signals
Indicator
OSIS
HAE
Relative Strength Index (RSI) 44.44 35.12
Support Level $247.20 $48.47
Resistance Level $276.56 $66.86
Average True Range (ATR) 12.64 1.85
MACD -1.82 0.05
Stochastic Oscillator 17.70 12.13

Price Performance

Historical Comparison
OSIS
HAE

About OSIS OSI Systems Inc. (DE)

OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems, and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. The majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East and Africa, and the Asia Pacific regions.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: